A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/27 (2006.01) A61K 38/21 (2006.01)
Patent
CA 2365070
The use of growth hormone (GH) together with an interferon (IFN) to produce a pharmaceutical composition for treating multiple sclerosis and/or other demyelinating diseases is disclosed. Disclosed are also said pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified therapy. In particular, the advantage ofEP0003504of GH together with IFN-.beta. to produce a pharmaceutical composition for the treatment of multiple sclerosis are shown.
L'invention concerne l'utilisation de l'hormone de croissance (GH) associée à un interféron (IFN) pour produire une composition pharmaceutique qui permet de traiter la sclérose en plaques et/ou d'autres maladies démyélinisantes. Elle concerne également l'utilisation simultanée, séparée ou séquentielle des principes actifs desdites compositions pharmaceutiques pour le traitement ci-dessus. Elle décrit en particulier les avantages de l'utilisation de la GH associée à l'IFN-.beta. pour produire une composition pharmaceutique permettant de traiter la sclérose en plaques.
Pagliusi Sonia
Sadoul Remy
Applied Research Systems Ars Holding N.v.
Kirby Eades Gale Baker
LandOfFree
Combined treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combined treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined treatment of multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1802930